Modern Chinese Medicine Group (1643) Delays Dispatch of Circular for Major Transaction

Bulletin Express02-09

Modern Chinese Medicine Group Co., Ltd. (Stock Code: 1643) previously announced on 19 January 2026 that it would issue a circular regarding its major transaction involving the acquisition of sale shares. The announcement indicated that the circular would be distributed on or before 9 February 2026 in accordance with Rule 14.41(a) of the Listing Rules.

The company has now stated that additional time is required to finalize information, including the consolidated audited report of the target group for the three years ended 31 December 2025. Consequently, the expected dispatch date for the circular has been delayed to on or before 30 April 2026.

The company has applied for a waiver from strict compliance with Rule 14.41(a) of the Listing Rules; however, the Stock Exchange has not yet granted the waiver as of the date of the announcement. The company will provide further updates as appropriate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment